Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp. (BIOX) Stock Competitors & Peer Comparison
See (BIOX) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Inputs Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BIOX | $0.45 | -16.94% | 28.5M | -0.43 | -$1.06 | N/A |
| CTA-PB | $68.37 | +0.31% | 59.3B | N/A | N/A | +0.85% |
| CTVA | $82.61 | -0.27% | 55.3B | 44.65 | $1.85 | +0.85% |
| CTA-PA | $53.51 | -1.15% | 35.9B | N/A | N/A | +6.60% |
| NTR | $71.98 | +0.97% | 34.6B | 14.66 | $4.91 | +3.04% |
| CF | $130.39 | +4.75% | 20B | 11.75 | $11.10 | +1.54% |
| ICL | $6.38 | -1.85% | 8.2B | 35.44 | $0.18 | +2.81% |
| MOS | $22.39 | +2.75% | 7.1B | 159.93 | $0.14 | +3.92% |
| SMG | $59.57 | -0.77% | 3.5B | 17.12 | $3.48 | +4.40% |
| FMC | $13.15 | +0.31% | 1.6B | -0.67 | -$19.62 | +9.95% |
Stock Comparison
BIOX vs CTA-PB Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, CTA-PB has a market cap of 59.3B. Regarding current trading prices, BIOX is priced at $0.45, while CTA-PB trades at $68.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas CTA-PB's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.06%, compared to CTA-PB's ROE of +0.05%. Regarding short-term risk, BIOX is more volatile compared to CTA-PB. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CTA-PB's competition here
BIOX vs CTVA Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, CTVA has a market cap of 55.3B. Regarding current trading prices, BIOX is priced at $0.45, while CTVA trades at $82.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas CTVA's P/E ratio is 44.65. In terms of profitability, BIOX's ROE is -1.06%, compared to CTVA's ROE of +0.05%. Regarding short-term risk, BIOX is more volatile compared to CTVA. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CTVA's competition here
BIOX vs CTA-PA Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, CTA-PA has a market cap of 35.9B. Regarding current trading prices, BIOX is priced at $0.45, while CTA-PA trades at $53.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas CTA-PA's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.06%, compared to CTA-PA's ROE of +0.05%. Regarding short-term risk, BIOX is more volatile compared to CTA-PA. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CTA-PA's competition here
BIOX vs NTR Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, NTR has a market cap of 34.6B. Regarding current trading prices, BIOX is priced at $0.45, while NTR trades at $71.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas NTR's P/E ratio is 14.66. In terms of profitability, BIOX's ROE is -1.06%, compared to NTR's ROE of +0.09%. Regarding short-term risk, BIOX is more volatile compared to NTR. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check NTR's competition here
BIOX vs CF Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, CF has a market cap of 20B. Regarding current trading prices, BIOX is priced at $0.45, while CF trades at $130.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas CF's P/E ratio is 11.75. In terms of profitability, BIOX's ROE is -1.06%, compared to CF's ROE of +0.35%. Regarding short-term risk, BIOX is more volatile compared to CF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CF's competition here
BIOX vs ICL Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, ICL has a market cap of 8.2B. Regarding current trading prices, BIOX is priced at $0.45, while ICL trades at $6.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas ICL's P/E ratio is 35.44. In terms of profitability, BIOX's ROE is -1.06%, compared to ICL's ROE of +0.04%. Regarding short-term risk, BIOX is more volatile compared to ICL. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check ICL's competition here
BIOX vs MOS Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, MOS has a market cap of 7.1B. Regarding current trading prices, BIOX is priced at $0.45, while MOS trades at $22.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas MOS's P/E ratio is 159.93. In terms of profitability, BIOX's ROE is -1.06%, compared to MOS's ROE of +0.06%. Regarding short-term risk, BIOX is more volatile compared to MOS. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check MOS's competition here
BIOX vs SMG Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, SMG has a market cap of 3.5B. Regarding current trading prices, BIOX is priced at $0.45, while SMG trades at $59.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas SMG's P/E ratio is 17.12. In terms of profitability, BIOX's ROE is -1.06%, compared to SMG's ROE of -0.34%. Regarding short-term risk, BIOX is more volatile compared to SMG. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check SMG's competition here
BIOX vs FMC Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, FMC has a market cap of 1.6B. Regarding current trading prices, BIOX is priced at $0.45, while FMC trades at $13.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas FMC's P/E ratio is -0.67. In terms of profitability, BIOX's ROE is -1.06%, compared to FMC's ROE of -0.83%. Regarding short-term risk, BIOX is more volatile compared to FMC. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check FMC's competition here
BIOX vs UAN Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, UAN has a market cap of 1.4B. Regarding current trading prices, BIOX is priced at $0.45, while UAN trades at $132.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas UAN's P/E ratio is 11.55. In terms of profitability, BIOX's ROE is -1.06%, compared to UAN's ROE of +0.40%. Regarding short-term risk, BIOX is more volatile compared to UAN. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check UAN's competition here
BIOX vs PURR Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, PURR has a market cap of 774.8M. Regarding current trading prices, BIOX is priced at $0.45, while PURR trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas PURR's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.06%, compared to PURR's ROE of -0.23%. Regarding short-term risk, BIOX is more volatile compared to PURR. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check PURR's competition here
BIOX vs IPI Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, IPI has a market cap of 627.1M. Regarding current trading prices, BIOX is priced at $0.45, while IPI trades at $46.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas IPI's P/E ratio is 42.05. In terms of profitability, BIOX's ROE is -1.06%, compared to IPI's ROE of +0.03%. Regarding short-term risk, BIOX is more volatile compared to IPI. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check IPI's competition here
BIOX vs AVD Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, AVD has a market cap of 83.8M. Regarding current trading prices, BIOX is priced at $0.45, while AVD trades at $2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas AVD's P/E ratio is -1.84. In terms of profitability, BIOX's ROE is -1.06%, compared to AVD's ROE of -0.22%. Regarding short-term risk, BIOX is more volatile compared to AVD. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check AVD's competition here
BIOX vs BHST Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, BHST has a market cap of 66.5M. Regarding current trading prices, BIOX is priced at $0.45, while BHST trades at $3.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas BHST's P/E ratio is -6.40. In terms of profitability, BIOX's ROE is -1.06%, compared to BHST's ROE of -1.59%. Regarding short-term risk, BIOX is more volatile compared to BHST. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check BHST's competition here
BIOX vs MULG Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, MULG has a market cap of 49.1M. Regarding current trading prices, BIOX is priced at $0.45, while MULG trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas MULG's P/E ratio is 18.21. In terms of profitability, BIOX's ROE is -1.06%, compared to MULG's ROE of +0.11%. Regarding short-term risk, BIOX is more volatile compared to MULG. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check MULG's competition here
BIOX vs BHIL-WT Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, BHIL-WT has a market cap of 49M. Regarding current trading prices, BIOX is priced at $0.45, while BHIL-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas BHIL-WT's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.06%, compared to BHIL-WT's ROE of -0.82%. Regarding short-term risk, BIOX is less volatile compared to BHIL-WT. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check BHIL-WT's competition here
BIOX vs FNUC Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, FNUC has a market cap of 31.6M. Regarding current trading prices, BIOX is priced at $0.45, while FNUC trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas FNUC's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.06%, compared to FNUC's ROE of -0.02%. Regarding short-term risk, BIOX is more volatile compared to FNUC. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check FNUC's competition here
BIOX vs CGA Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, CGA has a market cap of 29.3M. Regarding current trading prices, BIOX is priced at $0.45, while CGA trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas CGA's P/E ratio is -0.98. In terms of profitability, BIOX's ROE is -1.06%, compared to CGA's ROE of +0.04%. Regarding short-term risk, BIOX is more volatile compared to CGA. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CGA's competition here
BIOX vs LVRO Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, LVRO has a market cap of 15.1M. Regarding current trading prices, BIOX is priced at $0.45, while LVRO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas LVRO's P/E ratio is -0.03. In terms of profitability, BIOX's ROE is -1.06%, compared to LVRO's ROE of -1.11%. Regarding short-term risk, BIOX is more volatile compared to LVRO. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check LVRO's competition here
BIOX vs SEED Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, SEED has a market cap of 8.4M. Regarding current trading prices, BIOX is priced at $0.45, while SEED trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas SEED's P/E ratio is -1.07. In terms of profitability, BIOX's ROE is -1.06%, compared to SEED's ROE of +1.86%. Regarding short-term risk, BIOX is more volatile compared to SEED. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check SEED's competition here
BIOX vs AGRZ Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, AGRZ has a market cap of 7.2M. Regarding current trading prices, BIOX is priced at $0.45, while AGRZ trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas AGRZ's P/E ratio is 3.70. In terms of profitability, BIOX's ROE is -1.06%, compared to AGRZ's ROE of +0.37%. Regarding short-term risk, BIOX is more volatile compared to AGRZ. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check AGRZ's competition here
BIOX vs NITO Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, NITO has a market cap of 4.7M. Regarding current trading prices, BIOX is priced at $0.45, while NITO trades at $4.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas NITO's P/E ratio is -0.38. In terms of profitability, BIOX's ROE is -1.06%, compared to NITO's ROE of -0.46%. Regarding short-term risk, BIOX is more volatile compared to NITO. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check NITO's competition here
BIOX vs SVFD Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, SVFD has a market cap of 4.2M. Regarding current trading prices, BIOX is priced at $0.45, while SVFD trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas SVFD's P/E ratio is 0.07. In terms of profitability, BIOX's ROE is -1.06%, compared to SVFD's ROE of -462.29%. Regarding short-term risk, BIOX is more volatile compared to SVFD. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check SVFD's competition here
BIOX vs FMTO Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, FMTO has a market cap of 3.1M. Regarding current trading prices, BIOX is priced at $0.45, while FMTO trades at $3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas FMTO's P/E ratio is -0.00. In terms of profitability, BIOX's ROE is -1.06%, compared to FMTO's ROE of +75.78%. Regarding short-term risk, BIOX is less volatile compared to FMTO. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check FMTO's competition here
BIOX vs BHIL Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, BHIL has a market cap of 1.5M. Regarding current trading prices, BIOX is priced at $0.45, while BHIL trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas BHIL's P/E ratio is -0.01. In terms of profitability, BIOX's ROE is -1.06%, compared to BHIL's ROE of -0.82%. Regarding short-term risk, BIOX is more volatile compared to BHIL. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check BHIL's competition here
BIOX vs RKDA Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, RKDA has a market cap of 1.5M. Regarding current trading prices, BIOX is priced at $0.45, while RKDA trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas RKDA's P/E ratio is -0.62. In terms of profitability, BIOX's ROE is -1.06%, compared to RKDA's ROE of -0.41%. Regarding short-term risk, BIOX is more volatile compared to RKDA. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check RKDA's competition here
BIOX vs YTEN Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, YTEN has a market cap of 345.5K. Regarding current trading prices, BIOX is priced at $0.45, while YTEN trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas YTEN's P/E ratio is -0.02. In terms of profitability, BIOX's ROE is -1.06%, compared to YTEN's ROE of -15.08%. Regarding short-term risk, BIOX is less volatile compared to YTEN. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check YTEN's competition here
BIOX vs MBII Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, MBII has a market cap of 0. Regarding current trading prices, BIOX is priced at $0.45, while MBII trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas MBII's P/E ratio is -6.82. In terms of profitability, BIOX's ROE is -1.06%, compared to MBII's ROE of -0.54%. Regarding short-term risk, BIOX is less volatile compared to MBII. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check MBII's competition here
BIOX vs TNH Comparison May 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 28.5M. In comparison, TNH has a market cap of 0. Regarding current trading prices, BIOX is priced at $0.45, while TNH trades at $83.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.43, whereas TNH's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.06%, compared to TNH's ROE of +0.43%. Regarding short-term risk, BIOX is more volatile compared to TNH. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check TNH's competition here